Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ModA is the periplasmic binding protein component of the high-affinity molybdate ABC transporter system (ModABC) in Acinetobacter baumannii. It is responsible for scavenging trace amounts of molybdate from the environment and delivering it to the membrane-bound transport complex, which is essential for the biosynthesis of the molybdenum cofactor (MoCo). This cofactor is required for the function of various molybdoenzymes, such as nitrate reductase and xanthine dehydrogenase, which play critical roles in bacterial metabolism and survival, particularly under the anaerobic or low-oxygen conditions often encountered during host infection. As A. baumannii is a prominent multi-drug resistant (MDR) pathogen associated with severe hospital-acquired infections like pneumonia and sepsis, ModA has emerged as a potential therapeutic target for novel antibacterial strategies. By targeting the nutrient acquisition systems of the bacteria, researchers aim to starve the pathogen of essential trace elements, thereby attenuating its growth and virulence. While no drugs are currently approved specifically for this target, ModA is a subject of interest in structural genomics and anti-virulence drug discovery efforts aimed at overcoming antibiotic resistance.
Inhibition of molybdate uptake, leading to the depletion of essential molybdenum cofactors required for the activity of bacterial molybdoenzymes, thereby impairing metabolic function and reducing virulence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Molybdate-binding periplasmic protein (ModA) (ModA).